Avances en el estudio de marcadores moleculares en el diagnóstico y pronóstico de sepsis bacteriana en la ciudad de Cali

Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence. 2014; 5(1):36-44

Bozza F, Salluh J, Japiassu A, Soares M, Assis E, Gomes R, Bozza M, Castro-Faria-Neto H, Bozza P: Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11:R49.

Stanilova SA, Lyuba D. Miteva, Zhivko T. Karakolev, Chavdar S. Stefanov. Interleukin-10 -1082 promoter polymorphism in association whith cytokine production and sepsis susceptibility. Intensive Care Med 2006; 25: 260-266

Zeng L, Gu W, Chen K, Jiang D, Zhang L, Du D, Hu P, Liu Q, Huang S, Jiang J:Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. Crit Care 2009, 13:R188.

Faix JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci 2013; 50: 23-36

Pan W, Zhang AQ, Yue CL, Gao JW, Zeng L, Gu W, Jiang JX 2015. Association between interleukin-10 polymorphisms and sepsis: a meta-analysis. Epidemiol Infect 143: 366-375.

Stanilova SA, Functional relevance of IL-10 promoter polymorphisms for sepsis development. Stanilova Critical Care 2010; 14:119. http://ccforum.com/content/14/1/119.

Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012; 25: 609-634.

Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer Michael, et al. The Third International Consensus Definitions for Sepsis and Septic Choque (Sepsis-3). JAMA. 2016; 315(8):801-810. doi:10.1001/jama.2016.0287

Lowe PR, Galley HF, Abdel-Fattah A, Webster NR. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med. 2003 Jan;31(1):34-8. doi: 10.1097/00003246-200301000-00005.

Ouyang L, Lv YD, Hou C, Wu GB, He ZH. Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis. Molecular Biology Reports 2013; 40: 4327–4332.

-----------------------------------------------------------------------------------------------------------------------------

Dusan J, Zlatibor L, Krstina D, Aleksandar K. Intra-abdominal infection and acute abdomen-epidemiology, diagnosis and general principles of surgical management. Anamed. 2015;10(1):69-78

Quenot JP, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC, et al. The epidemiology of septic choque in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care. 2013;17(2):R65. http://doi.org/bwk2

Friedrich AK, Cahan M. Intraabdominal Infections in the Intensive Care Unit. J Intensive Care Med. 2013;29(5):247-254

Gaieski, D.F., Edwards, J.M., Kallan, M.J. & Carr, B.G. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 2013; 41, 1167–1174.

Reinhart K, Bauer M, Riedermann NC, Hartog CS. New approaches to sepsis: Molecular diagnostic and biomarkers. Clin Microbiol Rev. 2012;25:609–33

Evans HL, Raymond DP, Pelletier SJ, Crabtree TD, Pruett TL, Sawyer RG. Diagnosis of intra-abdominal infection in the critically ill patient. Curr Opin Crit Care 2001; 7:117–21.

Riese J, Schoolmann S, Denzel C, Herrmann O, Hohenberger W, Haupt W. Effect of abdominal infections on peritoneal and systemic production of interleukin 6 and monocyte chemoattractant protein-1. Shock 2002; 17:361–4.

Garcia-Sanchez JE, García-García MI, García-Garroteb F, Sánchez-Romeroc I. Microbiological diagnosis of intraabdominal infections. Enferm Infecc Microbiol Clin. 2012;31(4):230-239.

Kumar, H., Kawai, T. & Akira, S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30, 16–34.

Zhang A, Pan W, Gao J, Yue C, Zeng L, Gu W, et al. Associations between interleukin-1 gene polymorphisms and sepsis risk: a meta-analysis. BMC Med Genet. 2014;15:8-22. http://doi.org/bwm2

Lorenz E, Mira JP, Frees KL, et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162:1028–1032

Kagan JC and Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006; 125: 943–955.

Inohara C, McDonald C, Nunez G. NOD-LRR proteins: role in host–microbial interactions and inflammatory disease. Annu Rev Biochem 2005;74:355–383.

Angus DC, Burgner D, Wunderink R, et al. The PIRO concept: P is for predisposition. Crit Care 2003; 7: 248–251

Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players rules and the games. Immunology 2005;115:1–20